A detailed history of Black Rock Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 15,196,647 shares of CTLT stock, worth $853 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,196,647
Previous 16,176,100 6.05%
Holding current value
$853 Million
Previous $727 Million 18.03%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$42.56 - $59.82 $41.7 Million - $58.6 Million
-979,453 Reduced 6.05%
15,196,647 $858 Million
Q4 2023

Feb 13, 2024

BUY
$32.18 - $46.57 $17.4 Million - $25.2 Million
541,396 Added 3.46%
16,176,100 $727 Million
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $31.6 Million - $35.9 Million
715,827 Added 4.8%
15,634,704 $712 Million
Q2 2023

Aug 11, 2023

BUY
$31.86 - $67.26 $19.2 Million - $40.6 Million
603,729 Added 4.22%
14,918,877 $647 Million
Q1 2023

May 12, 2023

BUY
$45.44 - $74.26 $23.9 Million - $39.1 Million
525,992 Added 3.81%
14,315,148 $941 Million
Q4 2022

Feb 13, 2023

SELL
$41.39 - $81.0 $95.1 Million - $186 Million
-2,297,313 Reduced 14.28%
13,789,156 $620 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $57.4 Million - $89.7 Million
792,923 Added 5.18%
16,086,469 $1.16 Billion
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $29.4 Million - $38.5 Million
-337,474 Reduced 2.16%
15,293,546 $1.64 Billion
Q1 2022

May 12, 2022

BUY
$94.19 - $124.49 $59.6 Million - $78.8 Million
632,934 Added 4.22%
15,631,020 $1.73 Billion
Q4 2021

Feb 10, 2022

BUY
$119.57 - $139.07 $75.1 Million - $87.3 Million
627,853 Added 4.37%
14,998,086 $1.92 Billion
Q3 2021

Nov 09, 2021

BUY
$109.17 - $142.35 $5.04 Million - $6.57 Million
46,136 Added 0.32%
14,370,233 $1.91 Billion
Q2 2021

Aug 11, 2021

BUY
$100.34 - $115.69 $1.44 Billion - $1.66 Billion
14,324,097 New
14,324,097 $1.55 Billion

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.1B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.